Prostaglandin Analogs and Eupatilin as Treatments for Nephronophthisis
Our study indicates that these molecules can show beneficial effects across genetic contexts and shed light on their potential as therapeutic interventions for nephronophthisis.
Authors
- Sophie Saunier (ORCID: https://orcid.org/0000-0002-1069-0047)
- Marguerite Hureaux
- Gustavo Rocha (ORCID: https://orcid.org/0000-0001-6837-5528)
- Marc Fila (ORCID: https://orcid.org/0000-0001-8857-7100)
- Nicolas Cagnard (ORCID: https://orcid.org/0000-0002-9051-1896)
- Esther Porée (ORCID: https://orcid.org/0000-0002-7409-4850)
- Jean‐Philippe Annereau (ORCID: https://orcid.org/0000-0003-1248-8640)
- Luis Briseño-Roa (ORCID: https://orcid.org/0000-0002-8326-3329)
- Alice Tata (ORCID: https://orcid.org/0000-0002-9009-3698)
- Lilian Gréau
- Nicolas Goudin (ORCID: https://orcid.org/0000-0002-3967-4016)
- Alice Serafin (ORCID: https://orcid.org/0000-0003-2626-9748)
- Alexandre Benmerah (ORCID: https://orcid.org/0000-0003-0188-8016)
- Lucie Menguy
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Structure Fédérative de Recherche en Biologie et Santé de Rennes (FR)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.ekir.2025.04.060
- Primary Topic
- Genetic and Kidney Cyst Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00